Compare ASTH & HYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASTH | HYT |
|---|---|---|
| Founded | 1994 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Finance Companies |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2015 | N/A |
| Metric | ASTH | HYT |
|---|---|---|
| Price | $39.05 | $8.68 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $34.86 | N/A |
| AVG Volume (30 Days) | 412.4K | ★ 703.9K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.61% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.29 | N/A |
| Revenue | ★ $519,907,752.00 | N/A |
| Revenue This Year | $27.38 | N/A |
| Revenue Next Year | $10.78 | N/A |
| P/E Ratio | $78.17 | ★ N/A |
| Revenue Growth | ★ 45.90 | N/A |
| 52 Week Low | $18.08 | $8.22 |
| 52 Week High | $36.20 | $9.88 |
| Indicator | ASTH | HYT |
|---|---|---|
| Relative Strength Index (RSI) | 84.88 | 53.86 |
| Support Level | $20.62 | $8.22 |
| Resistance Level | N/A | $8.70 |
| Average True Range (ATR) | 1.54 | 0.06 |
| MACD | 0.18 | 0.00 |
| Stochastic Oscillator | 89.62 | 44.74 |
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
BlackRock Corporate High Yield Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to provide shareholders with current income. The trust's secondary investment objective is to provide shareholders with capital appreciation. Under Normal market conditions, the fund invests at least 80% of its net assets in high-yield securities of corporate issuers and derivatives that provide exposure to those securities or related market risk factors.